Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 7/2010

01-05-2010 | Case Report

Discoid lupus erythematosus in a patient with scleroderma and hepatitis C virus infection

Authors: Mami Yamamoto, Toshiyuki Yamamoto, Ryoji Tsuboi

Published in: Rheumatology International | Issue 7/2010

Login to get access

Abstract

A 49-year-old Japanese woman presented with discoid lupus erythematosus (DLE) on the face. The presence of Raynaud’s phenomenon, swollen fingers, a high anti-nuclear antibody titer, and the results of a biopsy revealed limited-type systemic sclerosis (lSSc). The association of SSc with DLE is rare, although some single case reports have been published in Japan. Our patient was positive for hepatitis C virus infection. Racial predisposition and immune imbalance are proposed to have played a role in the development of these lesions in our case.
Literature
1.
Chorzelski T, Jablónska S (1970) Coexistence of lupus erythematosus and scleroderma in light of immunopathological investigations. Acta Derm Venereol 50:81–85PubMed
2.
Sasaki T, Nakajima H (1993) Systemic sclerosis (scleroderma) associated with discoid lupus erythematosus. Dermatology 187:178–181CrossRefPubMed
3.
4.
5.
Metadata
Title
Discoid lupus erythematosus in a patient with scleroderma and hepatitis C virus infection
Authors
Mami Yamamoto
Toshiyuki Yamamoto
Ryoji Tsuboi
Publication date
01-05-2010
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2010
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1009-1

Other articles of this Issue 7/2010

Rheumatology International 7/2010 Go to the issue

Original Article

Single-nucleotide polymorphisms and expression of IL23R in Chinese ankylosing spondylitis patients

Original Article

Efficacy of EMG-biofeedback in knee osteoarthritis

Case Report

Charcot’s arthropathy secondary to herpetic encephalitis sequelae: an unusual presentation

Letter to the Editor

Incomplete (atypical) Kawasaki disease in a young infant with remarkable paucity of signs

Original Article

Demographic, clinical and mutational characteristics of Turkish familial Mediterranean fever patients: results of a single center in Central Anatolia

Original Article

Psychometric properties evaluation of the childhood health assessment questionnaire (CHAQ) in Moroccan juvenile idiopathic arthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits